Up to 40% of patients with bladder cancer have renal impairment ... discuss therapeutic strategies for patients with advanced TCC and renal impairment. It should be stressed that the ...

Bladder cancer is a common occurrence following the management of upper-tract TCC. Currently, there are no variables that consistently predict which patients will develop intravesical recurrences.

2 Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA 3 Department of General Internal Medicine/Palliative Medicine, Mayo Clinic, Rochester, Minnesota, USA Transitional cell ...

Cancer shows as a white spot on the scan. Urothelial carcinoma, previously called transitional cell carcinoma, forms in the urothelial cells lining the inside of the bladder. It makes up about 90% of ...

Data from the National Cancer Institute-funded Surveillance ... for a 35-year-old single male patient diagnosed with non-muscle invasive (T1) bladder TCC, poorly differentiated (grade III), without ...

The keywords used included transitional cell carcinoma, urothelial carcinoma, bladder cancer, bladder carcinoma, bladder metastasis, bladder tumor, lymph node metastasis, metastasis, and ...

The kidney, ureter, and bladder are lined with tissue called transitional epithelium. When cancer occurs within this lining it is called transitional cell carcinoma or "TCC." Traditional open surgery ...

The most recent positive transurethral resection of bladder tumor (TURBT ... locally advanced or metastatic urothelial cancer or concurrent extravesical, non–muscle-invasive TCC of the urothelium.